S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96

22nd Century Group Stock Forecast, Price & News

+0.14 (+6.57%)
(As of 07/5/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.61 million shs
Average Volume
2.10 million shs
Market Capitalization
$373.50 million
P/E Ratio
Dividend Yield
Price Target

22nd Century Group MarketRank™ Forecast

Analyst Rating
Short Interest
Dividend Strength
News Sentiment
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.44 out of 5 stars

Consumer Defensive Sector

2nd out of 5 stocks

Tobacco Industry

1st out of 1 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

About 22nd Century Group

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

XXII Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Year Founded


Pretax Margin


Sales & Book Value

Annual Sales


Free Float
Market Cap
$373.50 million

22nd Century Group Frequently Asked Questions

How has 22nd Century Group's stock performed in 2022?

22nd Century Group's stock was trading at $1.86 at the start of the year. Since then, XXII shares have increased by 22.0% and is now trading at $2.27.
View the best growth stocks for 2022 here

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the following people:
  • Mr. James A. Mish, CEO, Member of Scientific Advisory Board & Director (Age 58, Pay $1.09M)
  • Mr. Michael J. Zercher, Pres & COO (Age 51, Pay $1.04M)
  • Mr. Richard F. Fitzgerald CPA, CPA, Chief Financial Officer (Age 58, Pay $119.67k)
  • Mr. John E. Franzino, Chief Admin. Officer (Age 65, Pay $535.84k)
  • Dr. Calvin Treat, Chief Scientific Officer
  • Ms. Mei Kuo, Director of Communications & Investor Relations
  • Mr. Steven Przybyla, VP, Gen. Counsel & Corp. Sec.
  • Mr. Henry Sicignano III, M.B.A., MBA, Consultant (Age 54)
  • Mr. James C. Morrison, Technical Advisor & Regulatory Affairs Consultant

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "XXII."

How do I buy shares of 22nd Century Group?

Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 22nd Century Group's stock price today?

One share of XXII stock can currently be purchased for approximately $2.27.

How much money does 22nd Century Group make?

22nd Century Group (NYSE:XXII) has a market capitalization of $373.50 million.

How can I contact 22nd Century Group?

The official website for 22nd Century Group is www.xxiicentury.com. The company can be reached via phone at 716 270 1523.

This page (NYSE:XXII) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.